Abstract: Provided herein are methods and host cells for producing a polypeptide containing two chains, such as an antibody, half-antibody, antibody fragment, or one-armed antibody. The methods and host cells allow for two-chain polypeptide production using expression of polynucleotides encoding the polypeptide chains from extra-chromosomal polynucleotide(s), and expression of one or more chaperone protein(s) (e.g., peptidyl-prolyl isomerases and/or protein disulfide oxidoreductases) from the host cell chromosome using non-native combination(s) of promoters and translational units encoding a chaperone protein.

Abstract: The invention concerns a nutritional or therapeutic agent comprising a molecule mix obtained from Vitis vinifera and Vaccinium angustifolium, comprising: at least 1% of catechins and epicatechins, the percentage being given by weight in relation to the total weight of the mix, preferably at least 5%, at least 5 ppm (parts per million in the mix) of ferulic acid, preferably at least 10 ppm. The invention also relates to the use of this agent due to its effects on cognitive functions in particular.

Abstract: Provided herein are fermentation methods that improve the nutritional value and physical properties of microbial oil. Specifically, provided is a method of producing oil with increased omega-7 fatty acids. The method comprises culturing oil-producing microorganisms in a fermentation medium with less than 0.3 mg/L zinc, wherein the culturing produces an oil comprising fatty acids, wherein the oil comprises increased omega-7 fatty acids compared to a control oil. Optionally, the oil is isolated from the microorganisms of the culture.

Abstract: Methods for alleviating one or more symptoms and/or inhibiting muscle disuse atrophy in mammals via administration of compositions of egg powder protein are provided.

Abstract: The present invention provides a D-glucaric acid-producing bacterium and a method for producing D-glucaric acid. The present invention is characterized in that D-glucaric acid or a salt thereof is produced from one or more saccharides selected from the group consisting of D-glucose, D-gluconic acid and D-glucuronic acid with catalytic action of a specific alcohol dehydrogenase PQQ-ADH (1) and a specific aldehyde dehydrogenase PQQ-ALDH (2), and that D-glucaric acid or a salt thereof is produced by using a microorganism having the PQQ-ADH (1) and the PQQ-ALDH (2) or a processed product thereof in the presence of the one or more saccharides. The present invention can provide a microorganism having improved productivity of D-glucaric acid to be used for production of D-glucaric acid and a method for efficiently producing D-glucaric acid.

Abstract: This invention relates to the extraction of psychoactive compounds from fungus for use in medicine. Raw fungus is dried and ground. The solvent used for extraction is methanol or a hydro-methanol mixture, an acidic hydro-methanol mixture, or an alkaline hydro-methanol mixture. The extraction slurry is filtered and pH-adjusted if necessary. The methanol in the solvent is then completely evaporated and water added back, where necessary, to form a concentrated slurry. The concentrated slurry is then standardized to provide a known concentration of the psychoactive alkaloids that have been extracted. The standardized slurry may then be dried to result in a powdered extract with a precisely defined purity of psychoactive compounds.

Abstract: The invention provides a polyphenolic composition and method for its use and manufacture in the treatment of metabolic disorders. The active agents of the composition can include flavonoids and anthocyanins. The active agents can be obtained from rose petal extract, including Rosa multiflora rose petal extract. The composition finds use in the treatment of obesity and complications associated with obesity.

Abstract: Some embodiments comprise dietary supplements for treating or preventing traveler's diarrhea comprising: (a) about 1000 mg green tea extract comprising at least 90% (w/w) catechins; (b) about 4 g partially hydrolyzed guar gum (PHGG); (c) about 100 mg L-theanine; and (d) about 5 g non-sugar sweetener, wherein the sweetener does not contain a polyol. Some embodiments comprise dietary supplement for treating or preventing traveler's diarrhea comprising: (a)from about 250 mg to about 1,500 mg green tea extract comprising at least 90% (w/w) catechins; (b) from about 1 g to about 8 g partially hydrolyzed guar gum (PHGG); and (c) from about 15 mg to about 250 mg L-theanine.

Abstract: The present disclosure relates to compositions and methods for treating a subject having a COVID-19 infection. The present disclosure relates to the use of Dichrostachys glomerata extract as a medicament for the treatment of COVID-19 infections.

Abstract: An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron. The composition may include a combination of an extract of Magnolia officinalis and a extract of Phellodendron amurense. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or ?-aminobutyric acid (GABA).

Abstract: The present invention is directed to compositions comprising purified Bombyx mori cocoon silk peptide fiber, refined Buglossoides arvensis seed oil, and optionally Blueberry extract, and related methods for decreasing inflammation and providing neuroprotection. The compositions provide synergistic effects and may be used to treat relevant diseases and disorders.

Abstract: Disclosed is a two-dosage-form essence including oil gel and hydrogel. The oil gel and the hydrogel are mixed according to a preset ratio during use. The oil gel includes the following components in parts by weight: 0.1-6 parts of active ingredient; 15-35 parts of polyol; 0.1-1 part of SODIUM SURFACTIN; 10-70 parts of oil; and 1-10 parts of water. The two-dosage-form essence according to the present application is mixed according to a preset ratio during use, and the oil gel and the hydrogel have a transparent appearance and good stability. Also disclosed is a method for preparing a two-dosage-form essence. The oil gel and the hydrogel are prepared separately. The oil gel is prepared by a D-phase emulsification method. A low amount of emulsifier can emulsify an oil phase with a high oil content.

Abstract: The present disclosure provides a method for deodorizing a konjac tuber extract or konjac tuber powder containing glucosylceramide. With steam treatment including bringing steam into contact with a konjac tuber extract or konjac tuber powder containing glucosylceramide under a temperature condition of 100° C. or lower, a unique odor can be eliminated.

Abstract: A method for inhibiting microbial clogging of drip irrigation emitters, belonging to the technical field of water-saving irrigation. The method includes the following steps: (1) Use developmental molecular ecological network analysis to determine the key bacteria causing the clogging of drip irrigation emitters, and then carry out screening of antagonistic bacteria to inhibit the clogging of drip irrigation emitters; (2) Ferment the selected antagonistic bacteria in a medium containing biogas slurry, to generate bacterial antagonist; (3) Apply the bacterial antagonist to drip irrigation system. The method uses the molecular ecological network analysis method to obtain key bacteria that cause the growth of biofilm in drip irrigation emitters, and then combines the principle of microbial antagonism to screen out the antagonistic bacteria that can antagonize the growth of biofilm, so as to inhibit the growth of biofilm in irrigation emitters.

Abstract: The present invention relates to a method for modifying the glycosylation profile of a recombinant glycoprotein produced in cell culture comprising culturing eukaryotic cells expressing the recombinant glycoprotein in a cell culture medium, wherein the cell culture medium is supplemented with fucose, manganese, and taurine, wherein the glycosylation profile of the produced recombinant glycoprotein is modified to better resemble the glycosylation profile of a reference glycoprotein than when cultured without said supplementation.

Abstract: The present application relates to a plant-soaked solution comprising sugars containing tagatose and to a method for producing same.

Abstract: The present application relates to a plant-soaked solution including a saccharide containing allulose and a method of preparing the same.

Abstract: Rhynchophorus ferrugineus silver nanoparticles can be synthesized by mixing an aqueous larval gut extract of Rhynchophorus ferrugineus with an equal proportion of silver nitrate to provide a solution including Rhynchophorus ferrugineus silver nanoparticles. The Rhynchophorus ferrugineus silver nanoparticles can be useful as antibacterial agents.

Abstract: The present invention relates to an antimicrobial composition and probiotics against bacterial and fungal pathogens of fish. In particular, the invention pertains to a novel strain of the bacterial species Pseudomonas chlororaphis subsp. aurantiaca 1214-CHY4 (ATCC accession number PTA-126941), the cells, cell broth, and novel metabolites produced from the bacterial strain that can inhibit the growth of a variety of fish pathogens.

Abstract: The present invention relates to a method of using a recombinant antibacterial protein, termed Ablysin, for effectively killing multidrug-resistant pathogenic bacteria. The recombinant protein Ablysin is administered to prevent or treat infectious diseases caused by the antibiotic-resistant bacteria Acinetobacter baumannii. Ablysin can be widely used in antibiotics, disinfectants, food additives, feed additives, and the like. In particular, the Ablysin protein uses peptidoglycan, a component of the cell wall of bacteria, as a substrate and exhibits bacterial killing ability due to peptidoglycan degradation. The Ablysin of the present invention can be applied in the pharmaceutical industry, food industry, biotechnology, or similar industries, as the protein effectively kills bacteria at a desired place or in a target substance without problems of resistance that occurs in other antimicrobial agents.